Street-tablet quantification demonstrated variable bromazolam content, while postmortem detections did not define a standalone lethal concentration.
Forty-seven tablet samples submitted through UK drug-checking services and police were quantified using validated methods. Bromazolam content ranged from 0.09 to 5.4 mg per tablet, with a median of 0.49 mg. Many resembled licensed alprazolam or diazepam. Separately, national mortality reports identified 396 bromazolam-positive deaths, with an average of seven other substances detected per case.
Submitted tablets are not a random market sample, and the mortality data are not a controlled dose-response experiment. Co-detections, variable laboratory testing and postmortem conditions limit concentration interpretation. A median reported blood concentration cannot be used as a universal toxic or fatal threshold.
For a tablet or death opinion, establish identity and content analytically rather than from appearance. Keep the tablet dataset separate from the mortality dataset. The paper supports concerns about unpredictable exposure and mixed depressants, but cannot determine how many tablets a decedent consumed or isolate bromazolam’s contribution from a blood result alone.
Source reviewed: Bromazolam Tablet Quantification and Analysis of Post Mortem Cases From the National Programme on Su (PMC13040413). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Persistent Sedation After Naloxone Can Occur With Illicit-Benzodiazepine Co-Exposure.